Insights on Psychedelics: A Systematic Review of Therapeutic Effects
This systematic review (s=98) examining psychedelic-catalysed insight found that 86% of studies showed insight was linked to therapeutic improvement, with insight being dose-dependent and significantly higher than placebo in 93% of comparative studies, suggesting insight may be a key mechanism in psychedelic therapy.
Authors
- David Yaden
- Paul Liknaitzky
- Ruben Laukkonen
Published
Abstract
Background
Insight - a sudden change in understanding or perspective that feels true or reliable - is a common occurrence during psychedelic experiences, and often considered by clinicians and patients to be central to their therapeutic value. However, their occurrence and role has not been systematically assessed.
Objectives
We reviewed all peer-reviewed studies that published data on insight catalysed by a classic psychedelic at psychoactive levels, to elucidate several aspects of psychedelic-catalysed insight, including its prevalence, relationship to dose, time-course, and relationship to therapeutic outcomes. Risk of bias was assessed regarding selection, reliability, causality, and transparency.
Findings
The final database and key bibliography searches were completed on July 13, 2024. We screened 741 abstracts and included 98 studies (40 survey, 58 interventional). Insight was positively correlated with psychedelic dose, and was significantly higher following psychedelics in 43 of 46 (93%) studies that presented a comparison to a placebo condition. Crucially, 25 of 29 studies (86%) found that insight was associated with therapeutic improvement, and this relationship was often stronger than mystical-type experience, which has received more research attention.
Interpretation
This review indicates that psychedelic-catalysed insight is associated with therapeutic improvement, suggesting its importance for clinical practice and for understanding the mechanisms of psychedelic therapy.
Limitations
Heterogeneous study designs and operationalisations of insight precluded a meta-analytic summary. Publication bias and selective reporting is possible, given insight was typically not a primary outcome of the included studies.
Research Summary of 'Insights on Psychedelics: A Systematic Review of Therapeutic Effects'
Introduction
Psychedelic-assisted experiences at psychoactive doses commonly produce a range of acute subjective effects that have been linked to therapeutic benefit, including connectedness, emotional breakthrough, ego-dissolution and mystical-type experiences. Among these subjective changes, many users and clinicians report sudden, confidence‑laden changes in understanding—termed "insight"—which the authors define here as the sudden emergence of a change in perspective accompanied by clarity or certainty. Earlier studies have reported correlations between acute insight ratings and improvements in wellbeing, depression, anxiety and substance use, but insight itself has not been the subject of a comprehensive, systematic synthesis. Kugel and colleagues set out to fill that gap by conducting the first systematic review focused on psychedelic‑catalysed insight. The review aimed to characterise the prevalence of insight after psychoactive doses of classic serotonergic psychedelics, its relationship to dose, its time-course, and its association with therapeutic outcomes, and to compare insight with mystical‑type experiences as predictors of clinical benefit. The investigators also assessed risk of bias across included studies and made their protocol and materials openly available.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typemeta
- Journal
- Compounds
- Topics
- Authors
- APA Citation
Kugel, J., Laukkonen, R. E., Yaden, D. B., Yücel, M., & Liknaitzky, P. (2025). Insights on Psychedelics: A Systematic Review of Therapeutic Effects. Neuroscience & Biobehavioral Reviews, 173, 106117. https://doi.org/10.1016/j.neubiorev.2025.106117
References (53)
Papers cited by this study that are also in Blossom
Agin-Liebes, G. I., Lancelotta, R., Uthaug, M. V. et al. · ACS Pharmacology and Translational Science (2021)
Agin-Liebes, G. I., Malone, T., Yalch, M. M. et al. · Journal of Psychopharmacology (2020)
Aicher, H. D., Mueller, M. J., Dornbierer, D. A. et al. · Frontiers in Psychiatry (2024)
Barba, T., Buehler, S., Kettner, H. et al. · BJPsych Open (2022)
Carbonaro, T. M., Johnson, M. W., Griffiths, R. R. · Psychopharmacology (2020)
Carbonaro, T. M., Hurwitz, E., Johnson, M. W. · Psychopharmacology (2017)
Carhart-Harris, R. L., Bolstridge, &. M., Day, C. M. J. et al. · Psychopharmacology (2017)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Carhart-Harris, R. L., Nutt, D. J. · Journal of Substance Use (2010)
Davis, A. K., Barrett, F. S., Griffiths, R. R. · Journal of Contextual Behavioral Science (2020)
Show all 53 referencesShow fewer
Davis, A. K., Barrett, F. S., May, D. G. et al. · JAMA Psychiatry (2021)
Davis, A. K., Streeter Barrett, F., Griffiths, R. R. et al. · Journal of Psychopharmacology (2021)
Davis, A. K., Xin, Y., Sepeda, N. D. et al. · Chronic Stress (2021)
Doblin, R. · Journal of Transpersonal Psychology (1991)
Dyck, E. · Social History of Medicine (2006)
Fauvel, B., Strika-Bruneau, L., Piolino, P. · Psychology of Consciousness Theory Research and Practice (2023)
Garcia-Romeu, A., Davis, A. K., Griffiths, R. R. et al. · Frontiers in Psychiatry (2020)
Garcia-Romeu, A., Davis, A. K., Fire Erowid et al. · Journal of Psychopharmacology (2019)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Davis, A. K., Streeter Barrett, F., Cosimano, M. P. et al. · Journal of Psychopharmacology (2022)
Hendricks, P. S. · International Review of Psychiatry (2018)
Hirschfeld, T., Schmidt, T. T. · Journal of Psychopharmacology (2021)
Holze, F., Ley, L., Müller, F. et al. · Neuropsychopharmacology (2022)
James, E., Erritzoe, D., Benway, T. et al. · Frontiers in Psychiatry (2024)
Kettner, H., Roseman, L., Gazzaley, A. et al. · The American Journal of Geriatric Psychiatry (2024)
Ley, L., Holze, F., Arikci, D. et al. · Neuropsychopharmacology (2023)
Mason, N. L., Kuypers, K. P. C., Reckweg, J. T. et al. · Translational Psychiatry (2021)
McGovern, H., Grimmer, H. J., Doss, M. K. et al. · Communications Psychology (2024)
Moreton, S. G., Arena, A. F., Foy, Y. et al. · Death Studies (2023)
Moreton, S. G., Barr, N., Giese, K. J. · Death Studies (2024)
Moreton, S. G., Burden-Hill, A., Menzies, R. E. · Clinical Psychologist (2022)
Noorani, T., Garcia-Romeu, A., Swift, T. C. et al. · Journal of Psychopharmacology (2018)
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
Peill, J. M., Trinci, K. E., Kettner, H. et al. · Journal of Psychopharmacology (2022)
Roseman, L., Haijen, E. C. H. M., Idialu-Ikato, K. et al. · Journal of Psychopharmacology (2019)
Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)
Sanders, J. W. · ACS Pharmacology and Translational Science (2021)
Feusner, J. D., Wheaton, M. G., Gomez, G. J. et al. · Journal of Psychiatric Research (2023)
Simonsson, A., Simonsson, O., Chambers, R. et al. · Mindfulness (2023)
Simonsson, O., Hendricks, P. S., Chambers, R. et al. · Therapeutic Advances in Psychopharmacology (2022)
Smigielski, L., Kometer, M., Scheidegger, M. et al. · Scientific Reports (2019)
Timmermann, C., Watts, R., Dupuis, D. · Transcultural Psychiatry (2022)
Tolle, H. M., Farah, J. C., Mallaroni, P. et al. · Network Neuroscience (2024)
Tulver, K., Laukkonen, R., Aru, J. et al. · Psyarxiv (2022)
Uthaug, M. V., Lancelotta, R., Szabo, A. et al. · Psychopharmacology (2019)
Uthaug, M. V., Mason, N. L., Toennes, S. W. et al. · Psychopharmacology (2021)
Ramaekers, J. G. · Psychopharmacology (2022)
Schindowski, E. M., Jungwirth, J., Schuldt, A. et al. · EClinicalMedicine (2023)
Watts, R., Day, C. M., Krzanowski, J. et al. · Journal of Humanistic Psychology (2017)
Maia, L. O., Feilding, A., Ribeiro, S. et al. · Psychopharmacology (2021)
Williams, T. M., Davis, A. K., Xin, Y. et al. · Drugs Education Prevention and Policy (2020)
Xin, Y., Armstrong, S. B., Averill, L. A. et al. · Psychology of Consciousness Theory Research and Practice (2023)
Yaden, D. B., Goldy, S. P., Weiss, B. et al. · Nature Reviews Psychology (2024)
Cited By (2)
Papers in Blossom that reference this study
Jacobs, E., Zahid, Z., Hinkle, J. et al. · BMJ (2026)
Calnan, M., Blest-Hopley, G., Busch, C. et al. · Brain and Behavior (2025)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.